The Henry and Marilyn Taub Foundation Gives $1 Million to Pancreatic Cancer Action Network for Immunotherapy Research


Get Permission

The Henry and Marilyn Taub Foundation has presented a gift of $1 million to support the Shirley Sadoff Pancreatic Cancer Action Network Research Acceleration Network 2 Grant. The grant will support a large, multicenter phase II clinical trial studying an immunotherapeutic approach in patients with metastatic ­pancreatic ­cancer.

We hope that by funding research, we can improve the outcome for patients with pancreatic cancer.
— Marilyn Taub

Shirley Sadoff passed away from pancreatic cancer in 2000. Her sister, Marilyn Taub, cofounded The Henry and Marilyn Taub Foundation with her late husband, Henry Taub, in 1967. Henry Taub was the founder of Automatic Payrolls, now known as ADP.

“Too many people are taken by this horrible disease,” said Mrs. Taub. “We hope that by funding research, we can improve the outcome for patients with pancreatic cancer.”

David Linehan, MD

David Linehan, MD

Brian Wolpin, MD, MPH

Brian Wolpin, MD, MPH

David Linehan, MD, of the University of Rochester, and co–principal investigator Brian Wolpin, MD, MPH, of the Dana-Farber Cancer Institute, received the research acceleration network grant through a highly competitive, peer-reviewed process administered by the Pancreatic Cancer Action Network.

In conjunction with the clinical trial, Drs. Linehan and Wolpin will collect blood, bone marrow, and tumor biopsies to identify which biomarkers predict which patients will respond best to this promising approach.

“The brightest minds are attracted to difficult challenges,” said Julie Fleshman, JD, MBA, President and CEO of the Pancreatic Cancer Action Network. “With the generous support of the Henry and Marilyn Taub Foundation, we will bridge researchers with resources to improve treatment options for pancreatic cancer patients.” ■



Advertisement

Advertisement



Advertisement